Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

AORT stock hub

Artivion, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AORTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.2B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
AORT
In the news

Latest news · AORT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E97.7
P25 12.3P50 18.4P75 33.1
Trailing P/E105.4
P25 14.9P50 23.2P75 38.5
ROE3.1
P25 -105.6P50 -46.5P75 -3.1
ROIC3.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AORT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
254
Groups with data
11
Currency
USD
Showing 254 of 254 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0000784199
Company name
Artivion, Inc.
Country
United States
Country code
US
Cusip
228903100
Employees
1,800
Employees Change
200%
Employees Change Percent
12.5
Enterprise value
$1.4B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
1993-02-11
Isin
US2289031005
Last refreshed
2026-05-10
Market cap
$1.2B
Market cap category
Small-Cap
Price
$25.41
Price currency
USD
Rev Per Employee
254,827.22x
Sector
Healthcare
Sic
3841
Symbol
AORT
Website
https://artivion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
0.95%
EV Earnings
122.97x
EV Sales Forward
2.77x
EV/EBIT
37.74x
EV/EBITDA
23.38x
EV/FCF
98.48x
EV/Sales
3.13x
FCF yield
1.18%
Forward P/E
97.73x
P/B ratio
2.74x
P/E ratio
105.43x
P/S ratio
2.69x
PS Forward
2.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
8.3%
EBITDA Margin
13.39%
FCF margin
3.18%
Gross margin
64.55%
Gross Profit
$296.1M
Gross Profit Growth
18.72%
Gross Profit Growth Q
18.67%
Gross Profit Growth3 Y
12.94%
Gross Profit Growth5 Y
11.55%
Net Income
$11.7M
Net Income Growth Quarters
4%
Net Income Growth Years
2%
Pretax Margin
3.8%
Profit Margin
2.55%
Profit Per Employee
$6,487
Profitable Years
1
ROA
2.84
Roa5y
0.75
ROCE
4.81
ROE
3.14
Roe5y
-4.84
ROIC
3.95
Roic5y
1.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr10y
7.57%
Cagr15y
11.24%
Cagr1y
-10.47%
Cagr20y
8.73%
Cagr3y
18.7%
Cagr5y
-3.69%
EPS Growth Quarters
4
EPS Growth Years
2
FCF Growth5 Y
104.87%
OCF Growth
438.11%
OCF Growth10 Y
17.51%
OCF Growth5 Y
54%
Revenue Growth
17.59x
Revenue Growth Q
17.54x
Revenue Growth Quarters
21x
Revenue Growth Years
5x
Revenue Growth3 Y
12.77x
Revenue Growth5 Y
12.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.55
Assets
$883.2M
Cash
$55.8M
Current Assets
$357.5M
Current Liabilities
$92.7M
Debt
$258.2M
Debt EBITDA
$3.74
Debt Equity
$0.57
Debt FCF
$17.71
Equity
$450.5M
Interest Coverage
1.56
Liabilities
$432.7M
Long Term Assets
$525.6M
Long Term Liabilities
$340M
Net Cash
$-202.4M
Net Cash By Market Cap
$-16.41
Net Debt EBITDA
$3.3
Net Debt Equity
$0.45
Net Debt FCF
$13.88
Tangible Book Value
$43.9M
Tangible Book Value Per Share
$0.91
WACC
11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.86
Inventory Turnover
1.81
Net Working Capital
$214.6M
Quick ratio
1.74
Working Capital
$264.8M
Working Capital Turnover
$1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-17%
Dividend per share
$0
Dividend Yield
0%
Last Dividend
$0.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
107.43%
1Y total return
-10.47%
200-day SMA
40.71
3Y total return
67.28%
50-day SMA
36.29
50-day SMA vs 200-day SMA
50under200
5Y total return
-17.12%
All Time High
48.25
All Time High Change
-47.34%
All Time High Date
2025-12-17
All Time Low
1.4
All Time Low Change
1,715%
All Time Low Date
2002-08-15
ATR
2.57
Beta
1.4
Beta1y
1.11
Beta2y
0.83
Ch YTD
-44.29
High
27.31
High52
48.25
High52 Date
2025-12-17
High52ch
-47.34%
Low
19.16
Low52
19.16
Low52 Date
2026-05-08
Low52ch
32.62%
Ma50ch
-29.99%
Premarket Change Percent
-29.14
Premarket Price
$25.1
Premarket Volume
3,540
Price vs 200-day SMA
-37.58%
RSI
23.41
RSI Monthly
41.47
RSI Weekly
22.93
Sharpe ratio
-0.04x
Sortino ratio
0.05
Total Return
-17%
Tr YTD
-44.29
Tr15y
394.28%
Tr1m
-27.85%
Tr1w
-29.83%
Tr3m
-35.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

16
MetricValue
Analyst Count
5
Analyst Count Top
1
Analyst Price Target Top
$46
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$0.11
Earnings EPS Estimate Growth
83.33
Earnings Revenue Estimate
115,783,000x
Earnings Revenue Estimate Growth
16.98x
Operating Income
$38.1M
Operating Income Growth
95.77
Operating Income Growth5 Y
29.21
Operating margin
8.3
Price target
$45.6
Price Target Change
$79.46
Price Target Change Top
$81.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
46,026,081%
Float Percent
94.81%
Net Borrowing
-2,971,000
Shares Insiders
5.17%
Shares Institutions
92.46%
Shares Out
48,543,350
Shares Qo Q
0.26%
Shares Yo Y
17%
Short Float
4.22%
Short Ratio
4.32
Short Shares
4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

74
MetricValue
Adjusted FCF
$-10.2M
Average Volume
573,572.7x
Bv Per Share
9.29
CAPEX
$-43.4M
Ch10y
107.4
Ch15y
371.4
Ch1m
-27.85
Ch1w
-29.83
Ch1y
-10.47
Ch20y
408.2
Ch3m
-35.82
Ch3y
67.28
Ch5y
-17.12
Ch6m
-43.37
Change
-28.26%
Change From Open
-6.96
Close
35.42
Days Gap
-22.9
Depreciation Amortization
23,352,000
Dollar Volume
130,527,409.3
Earnings Date
2026-05-07
Earnings Time
amc
EBIT
$38.1M
EBITDA
$61.4M
EPS
$0.24
F Score
7
FCF
$14.6M
FCF EV Yield
1.02x
FCF Per Share
$0.3
Financing CF
7,808,000
Fiscal Year End
December
Founded
1,984
Goodwill
251,660,000
Graham Number
7.09717
Graham Upside
-72.07
Income Tax
$5.7M
Investing CF
-48,906,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2000-12-28
Last Split Type
Forward
Last10k Filing Date
2026-02-18
Ma150
40.97
Ma150ch
-37.97%
Ma20
36.14
Ma20ch
-29.69%
Net CF
18,071,000
Next Earnings Date
2026-08-06
Open
27.31
Optionable
Yes
P FCF Ratio
84.6
P OCF Ratio
21.27
Position In Range
76.69
Post Close
25.41
Postmarket Change Percent
-0.31
Postmarket Price
$25.33
Ppne
102,299,000
Pre Close
35.42
Price Date
2026-05-08
Price EBITDA
$20.09
Ptbv Ratio
28.08
Relative Volume
8.96x
Revenue
458,689,000x
SBC By Revenue
5.4x
Share Based Comp
24,754,000
Tax By Revenue
1.25x
Tax Rate
32.87%
Tr20y
432.83%
Tr6m
-43.37%
Us State
Georgia
Volume
5,136,852
Z Score
3.36
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AORT pay a dividend?

Capital-return profile for this ticker.

Performance

AORT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-10.5%
S&P 500 1Y: n/a
3Y total return
+67.3%
S&P 500 3Y: n/a
5Y total return
-17.1%
S&P 500 5Y: n/a
10Y total return
+107.4%
S&P 500 10Y: n/a
Ownership

Who owns AORT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+92.5%
Float: +94.8% of shares outstanding
Insider ownership
+5.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+4.2%
4.3 days to cover
Y/Y dilution
+17.0%
Negative means the company is buying back shares.
Technical

AORT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
23.4
Below 30: short-term oversold
Price vs 200-day MA
-37.6%
50/200-day relationship not available
Beta (5Y)
1.40
More volatile than the market
Sharpe ratio
-0.04
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AORT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AORT stock rating?

Artivion, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AORT analysis?

The full report lives at /stocks/AORT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AORT?

The latest report frames AORT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AORT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.